Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.89 USD | -0.89% | -3.89% | +11.68% |
04-24 | Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Wednesday Amid Earnings Deluge | MT |
04-24 | Centessa Pharmaceuticals Prices Equity Offering at $9.25 Per ADS | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.68% | 1B | |
+26.31% | 44.96B | |
-0.90% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.47% | 26.08B | |
-21.29% | 19.03B | |
+6.03% | 12.75B | |
+28.51% | 12.06B | |
-3.35% | 11.75B |
- Stock Market
- Equities
- CNTA Stock
- News Centessa Pharmaceuticals plc
- Centessa Pharmaceutical Gets FDA's Approval to Begin Phase 1 Trial of Narcolepsy Drug Candidate